Dexcom's G7 Glucose Monitor Shows Significant Benefits for Non-Insulin Diabetics
Dexcom's glucose monitor use benefits non-insulin diabetic patients: Study
Business StandardImage: Business Standard
A study presented at the American Diabetes Association found that Dexcom's G7 continuous glucose monitor significantly improved blood sugar control in non-insulin dependent type 2 diabetes patients, reducing levels by an average of 1.6% over 26 weeks compared to standard care.
- 01The study involved 283 non-insulin using diabetic patients over 26 weeks.
- 02Participants using the G7 monitor achieved a 1.6% reduction in blood sugar, outperforming the control group by 0.9%.
- 03Common diabetes medications like metformin were used alongside the G7 monitor.
- 04Patients on GLP-1 drugs using the G7 saw a 1.4% drop in blood sugar, compared to 0.2% in the control group.
- 05The study's findings may influence the standard of care for type 2 diabetes globally.
Advertisement
In-Article Ad
Dexcom's G7 continuous glucose monitor has been shown to enhance blood sugar management in patients with type 2 diabetes who do not use insulin, according to a study presented at the American Diabetes Association. The 26-week trial involved 283 participants, half of whom utilized the G7 device while the other half relied on traditional self-monitoring methods. Those using the G7 experienced an average blood sugar reduction of 1.6%, which is 0.9% greater than the control group. The study also highlighted that combining the G7 with common diabetes medications, such as metformin and GLP-1s, led to further improvements in blood sugar levels. Notably, participants on GLP-1 drugs using the G7 saw a 1.4% decrease in their blood sugar compared to just 0.2% in the control group. Dexcom's CEO, Jake Leach, emphasized the study's implications for establishing a new standard of care for diabetes management, which could lead to increased access to continuous glucose monitoring for all type 2 diabetes patients. A six-month extension of the study is currently underway to gather additional data.
Advertisement
In-Article Ad
The findings from this study may lead to broader adoption of continuous glucose monitors among non-insulin dependent diabetes patients, improving their health outcomes.
Advertisement
In-Article Ad
Reader Poll
Do you believe continuous glucose monitors should be more widely used for non-insulin dependent diabetes?
Connecting to poll...
Read the original article
Visit the source for the complete story.



